Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GE HealthCare Technologies Inc. - Common Stock (NQ: GEHC )

85.39 -0.55 (-0.64%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,365,317
Open 87.00
Bid (Size) 84.52 (1)
Ask (Size) 86.58 (1)
Prev. Close 85.94
Today's Range 84.47 - 87.15
52wk Range 66.39 - 94.55
Shares Outstanding N/A
Dividend Yield 0.07%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GE HealthCare And DeepHealth Team Up To Advance AI-Powered Breast Cancer Screening: Details
GE HealthCare and DeepHealth collaborate to develop AI-powered solutions for imaging, starting with breast cancer screening. 
Via Benzinga
GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™
From GE HealthCare Technologies Inc.
Via Business Wire

Performance

YTD
+11.81%
+11.81%
1 Month
-6.20%
-6.20%
3 Month
+3.67%
+3.67%
6 Month
+5.38%
+5.38%
1 Year
+21.97%
+21.97%

More News

Read More
GE HealthCare Technologies Inc. Prices Secondary Offering of 13,281,302 Shares
From GE HealthCare Technologies Inc.
Via Business Wire
Analyst Scoreboard: 4 Ratings For GE HealthCare Techs
Via Benzinga
GE HealthCare Technologies Inc. Commences Secondary Offering of 13,281,302 Shares
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare to Host its 2024 Investor Day on November 21
From GE HealthCare
Via Business Wire
GE HealthCare reports third quarter 2024 financial results
From GE HealthCare
Via Business Wire
GE Vernova Earnings Miss On This Big Headwind
Via Investor's Business Daily
Topics Earnings
Exposures Financial
GE Vernova Vs. GE Healthcare: Betting On Power Or Medical Tech To Lead AI-Powered Future?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
GE HealthCare Announces AI Innovation Lab Showcasing Five New Research Projects
From GE HealthCare
Via Business Wire
GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view
From GE HealthCare
Via Business Wire
GE HealthCare, the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation commit $1M to improve Milwaukee health outcomes
From GE HealthCare
Via Business Wire
GE HealthCare announces major academic medical center as first customer to adopt new Hospital Pulse Tile for Command Center
From GE HealthCare Technologies Inc.
Via Business Wire
A New Theranostics Center of Excellence in Europe: GE HealthCare and University Medicine Essen Collaborate to Advance Theranostics and Personalized Medicine
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare introduces easy-to-use, easy-to-learn, easy-to-diagnose Versana Premier multi-purpose ultrasound system
From GE HealthCare
Via Business Wire
Jim Cramer Likes Reddit Very Much, Calls Accenture A 'Great Buy'
Via Benzinga
GE HealthCare Accelerates Artificial Intelligence Adoption With New Offering to Advance Enterprise Imaging
From GE HealthCare
Via Business Wire
Dow Giant Eyes Possible $10 Billion Spinoff; Is It The Next GE?
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
GE HealthCare to announce third quarter 2024 results on October 30, 2024
From GE HealthCare
Via Business Wire
GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe
From GE HealthCare
Via Business Wire
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
From GE HealthCare
Via Business Wire
The New Face of GE: Why Aerospace Might Be Worth the Wait
Via The Motley Fool
Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 28
Via Talk Markets
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
From GE HealthCare Technologies Inc.
Via Business Wire
GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024
From GE HealthCare
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.